Interruption of the long non-coding RNA HOTAIR signaling axis ameliorates chemotherapy-induced cachexia in bladder cancer

Saini A, Al-Shanti N, Stewart CE. Waste management—cytokines, growth factors and cachexia. Cytokine Growth Factor Rev. 2006;17(6):475–86.

Article  Google Scholar 

Webster JM, Kempen L, Hardy RS, Langen RCJ. Inflammation and skeletal muscle wasting during cachexia. Front Physiol. 2020;11: 597675.

Article  Google Scholar 

Op den Kamp CM, Langen RC, Snepvangers FJ, de Theije CC, Schellekens JM, Laugs F, et al. Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia. Am J Clin Nutr. 2013;98(3):738–48.

Article  Google Scholar 

Riccardi D, das Neves RX, de Matos-Neto EM, Camargo RG, Lima J, Radloff K, et al. Plasma lipid profile and systemic inflammation in patients with cancer cachexia. Front Nutr. 2020;7:4.

Article  Google Scholar 

Rausch V, Sala V, Penna F, Porporato PE, Ghigo A. Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia. Oncogenesis. 2021;10(1):1.

Article  Google Scholar 

Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-kappaB signaling in inflammation and cancer. MedComm (2020). 2021;2(4):618–53.

Google Scholar 

Thoma A, Lightfoot AP. NF-kB and inflammatory cytokine signalling: role in skeletal muscle atrophy. Adv Exp Med Biol. 2018;1088:267–79.

Article  Google Scholar 

Fukushima H, Takemura K, Suzuki H, Koga F. Impact of sarcopenia as a prognostic biomarker of bladder cancer. Int J Mol Sci. 2018;19(10):2999.

Article  Google Scholar 

Rimar KJ, Glaser AP, Kundu S, Schaeffer EM, Meeks J, Psutka SP. Changes in lean muscle mass associated with neoadjuvant platinum-based chemotherapy in patients with muscle invasive bladder cancer. Bladder Cancer. 2018;4(4):411–8.

Article  Google Scholar 

Damrauer JS, Stadler ME, Acharyya S, Baldwin AS, Couch ME, Guttridge DC. Chemotherapy-induced muscle wasting: association with NF-kappaB and cancer cachexia. Eur J Transl Myol. 2018;28(2):7590.

Article  Google Scholar 

Conte E, Bresciani E, Rizzi L, Cappellari O, De Luca A, Torsello A, et al. Cisplatin-induced skeletal muscle dysfunction: mechanisms and counteracting therapeutic strategies. Int J Mol Sci. 2020;21(4):1242.

Article  Google Scholar 

Sakai H, Sagara A, Arakawa K, Sugiyama R, Hirosaki A, Takase K, et al. Mechanisms of cisplatin-induced muscle atrophy. Toxicol Appl Pharmacol. 2014;278(2):190–9.

Article  Google Scholar 

Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer. 2001;37(Suppl 4):S9-15.

Article  Google Scholar 

Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL. The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer. 1990;65(7):1619–25.

Article  Google Scholar 

Benhar M, Engelberg D, Levitzki A. Cisplatin-induced activation of the EGF receptor. Oncogene. 2002;21(57):8723–31.

Article  Google Scholar 

Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 1996;379(6565):557–60.

Article  Google Scholar 

Hugo de Almeida V, Guimaraes IDS, Almendra LR, Rondon AMR, Tilli TM, de Melo AC, et al. Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer. Oncotarget. 2018;9(55):30594–609.

Article  Google Scholar 

Hsu SC, Miller SA, Wang Y, Hung MC. Nuclear EGFR is required for cisplatin resistance and DNA repair. Am J Transl Res. 2009;1(3):249–58.

Google Scholar 

Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311–23.

Article  Google Scholar 

Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–6.

Article  Google Scholar 

Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329(5992):689–93.

Article  Google Scholar 

Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–81.

Article  Google Scholar 

Rajagopal T, Talluri S, Akshaya RL, Dunna NR. HOTAIR LncRNA: a novel oncogenic propellant in human cancer. Clin Chim Acta. 2020;503:1–18.

Article  Google Scholar 

Zhang Z, Fan B, Liu F, Song N, Peng Y, Ma W, et al. HOX transcript antisense RNA is elevated in gastric carcinogenesis and regulated by the NF-kappaB pathway. J Cell Biochem. 2019;120(6):10548–55.

Article  Google Scholar 

Ozes AR, Miller DF, Ozes ON, Fang F, Liu Y, Matei D, et al. NF-kappaB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene. 2016;35(41):5350–61.

Article  Google Scholar 

Obaid M, Udden SMN, Deb P, Shihabeddin N, Zaki MH, Mandal SS. LncRNA HOTAIR regulates lipopolysaccharide-induced cytokine expression and inflammatory response in macrophages. Sci Rep. 2018;8(1):15670.

Article  Google Scholar 

Lee J, Kang H. Role of MicroRNAs and long non-coding RNAs in sarcopenia. Cells. 2022;11(2):187.

Article  Google Scholar 

Ueda H, Matsunaga H, Halder SK. Prothymosin alpha plays multifunctional cell robustness roles in genomic, epigenetic, and nongenomic mechanisms. Ann N Y Acad Sci. 2012;1269:34–43.

Article  Google Scholar 

Wu CL, Shiau AL, Lin CS. Prothymosin alpha promotes cell proliferation in NIH3T3 cells. Life Sci. 1997;61(21):2091–101.

Article  Google Scholar 

Su BH, Tseng YL, Shieh GS, Chen YC, Shiang YC, Wu P, et al. Prothymosin alpha overexpression contributes to the development of pulmonary emphysema. Nat Commun. 2013;4:1906.

Article  Google Scholar 

Su YC, Ou HY, Wu HT, Wu P, Chen YC, Su BH, et al. Prothymosin-alpha overexpression contributes to the development of insulin resistance. J Clin Endocrinol Metab. 2015;100(11):4114–23.

Article  Google Scholar 

Jou YC, Tung CL, Tsai YS, Shen CH, Syue-Yi C, Shiau AL, et al. Prognostic relevance of prothymosin-alpha expression in human upper urinary tract transitional cell carcinoma. Urology. 2009;74(4):951–7.

Article  Google Scholar 

Samara P, Karachaliou CE, Ioannou K, Papaioannou NE, Voutsas IF, Zikos C, et al. Prothymosin Alpha: an Alarmin and More. Curr Med Chem. 2017;24(17):1747–60.

Article  Google Scholar 

Shiau AL, Chen YL, Liao CY, Huang YS, Wu CL. Prothymosin alpha enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis. Vaccine. 2001;19(28–29):3947–56.

Article  Google Scholar 

Shiau AL, Chen CC, Yo YT, Chu CY, Wang SY, Wu CL. Enhancement of humoral and cellular immune responses by an oral Salmonella choleraesuis vaccine expressing porcine prothymosin alpha. Vaccine. 2005;23(48–49):5563–71.

Article  Google Scholar 

Omotuyi O, Matsunaga H, Ueda H. Evidence for ProTalpha-TLR4/MD-2 binding: molecular dynamics and gravimetric assay studies. Expert Opin Biol Ther. 2015;15(Suppl 1):S223-229.

Article  Google Scholar 

Halder SK, Matsunaga H, Ishii KJ, Ueda H. Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina. J Neurochem. 2015;135(6):1161–77.

Article  Google Scholar 

Tsai YS, Jou YC, Lee GF, Chen YC, Shiau AL, Tsai HT, et al. Aberrant prothymosin-alpha expression in human bladder cancer. Urology. 2009;73(1):188–92.

Article  Google Scholar 

Tzai TS, Tsai YS, Shiau AL, Wu CL, Shieh GS, Tsai HT. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer. Urology. 2006;67(2):294–9.

Article  Google Scholar 

Li KJ, Shiau AL, Chiou YY, Yo YT, Wu CL. Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease. Kidney Int. 2005;67(5):1710–22.

Article  Google Scholar 

Kuo FC, Huang YC, Yen MR, Lee CH, Hsu KF, Yang HY, et al. Aberrant overexpression of HOTAIR inhibits abdominal adipogenesis through remodelling of genome-wide DNA methylation and transcription. Mol Metab. 2022;60: 101473.

Article  Google Scholar 

Chen YC, Kuo PY, Chou YC, Chong HE, Hsieh YT, Yang ML, et al. Up-regulated expression of pro-apoptotic long noncoding RNA lincRNA-p21 with enhanced cell apoptosis in lupus nephritis. Int J Mol Sci. 2020;22(1):301.

Article  Google Scholar 

Wang CR, Shiau AL, Chen SY, Cheng ZS, Li YT, Lee CH, et al. Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis. Gene Ther. 2010;17(10):1225–33.

Article  Google Scholar 

Sun R, Zhang S, Hu W, Lu X, Lou N, Yang Z, et al. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPbeta-regulated atrogin1 expression in cancer cachexia. Am J Physiol Cell Physiol. 2016;311(1):C101-115.

Article  Google Scholar 

Jackman RW, Floro J, Yoshimine R, Zitin B, Eiampikul M, El-Jack K, et al. Continuous release of tumor-derived factors improves the modeling of cachexia in muscle cell culture. Front Physiol. 2017;8:738.

Article  Google Scholar 

Zhang W, Sun W, Gu X, Miao C, Feng L, Shen Q, et al. GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway. Cell Death Discov. 2022;8(1):162.

Article  Google Scholar 

Wang CR, Chen SY, Wu CL, Liu MF, Jin YT, Chao L, et al. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. Arthritis Rheum. 2005;52(4):1319–24.

Article  Google Scholar 

Marzouka NA, Eriksson P, Rovira C, Liedberg F, Sjodahl G, Hoglund M. A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort. Sci Rep. 2018;8(1):3737.

Article  Google Scholar 

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–10.

Article  Google Scholar 

Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. J Biol Chem. 2005;280(11):10326–32.

Article  Google Scholar 

Shin HM, Kim MH, Kim BH, Jung SH, Kim YS, Park

留言 (0)

沒有登入
gif